Anish Patel

Insider Reports History

Location
Boulder, CO
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anish Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. CHIEF OPERATING OFFICER Common Stock 215,011 $5,456,979 $25.38 12 Feb 2026 Indirect
Enliven Therapeutics, Inc. CHIEF OPERATING OFFICER Common Stock 20,000 $507,600 $25.38 12 Feb 2026 Direct
Enliven Therapeutics, Inc. CHIEF OPERATING OFFICER Stock Option (right to buy) 120,000 12 Feb 2026 Direct

Insider Reports Filed by Anish Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 2 $0 4 CHIEF OPERATING OFFICER 17 Feb 2026, 19:53
ELVN Enliven Therapeutics, Inc. 09 Jan 2026 2 -$1,351,762 4 CHIEF OPERATING OFFICER 13 Jan 2026, 17:54
ELVN Enliven Therapeutics, Inc. 08 Dec 2025 2 -$140,073 4 CHIEF OPERATING OFFICER 10 Dec 2025, 17:13
ELVN Enliven Therapeutics, Inc. 07 Nov 2025 2 -$116,034 4 CHIEF OPERATING OFFICER 12 Nov 2025, 17:34
ELVN Enliven Therapeutics, Inc. 07 Oct 2025 1 -$133,993 4 CHIEF OPERATING OFFICER 09 Oct 2025, 17:21
ELVN Enliven Therapeutics, Inc. 08 Sep 2025 1 -$134,957 4 CHIEF OPERATING OFFICER 10 Sep 2025, 20:12
ELVN Enliven Therapeutics, Inc. 07 Aug 2025 2 -$121,616 4 CHIEF OPERATING OFFICER 11 Aug 2025, 18:51
ELVN Enliven Therapeutics, Inc. 07 Jul 2025 2 -$131,951 4 CHIEF OPERATING OFFICER 09 Jul 2025, 19:29
ELVN Enliven Therapeutics, Inc. 09 Jun 2025 2 -$135,574 4 CHIEF OPERATING OFFICER 11 Jun 2025, 18:25
ELVN Enliven Therapeutics, Inc. 07 May 2025 3 -$122,579 4 CHIEF OPERATING OFFICER 09 May 2025, 18:48
ELVN Enliven Therapeutics, Inc. 07 Apr 2025 3 -$120,269 4 CHIEF OPERATING OFFICER 09 Apr 2025, 16:25
ELVN Enliven Therapeutics, Inc. 07 Mar 2025 1 -$142,936 4 CHIEF OPERATING OFFICER 11 Mar 2025, 17:18
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 2 -$146,206 4 CHIEF OPERATING OFFICER 10 Feb 2025, 17:32
ELVN Enliven Therapeutics, Inc. 07 Jan 2025 10 -$646,604 4 CHIEF OPERATING OFFICER 10 Jan 2025, 17:31
ELVN Enliven Therapeutics, Inc. 18 Oct 2024 1 -$21,483 4 CHIEF OPERATING OFFICER 22 Oct 2024, 16:23
ELVN Enliven Therapeutics, Inc. 12 Jul 2024 3 -$1,252,826 4 CHIEF OPERATING OFFICER 16 Jul 2024, 17:37
ELVN Enliven Therapeutics, Inc. 06 Jun 2024 3 -$19,913 4 CHIEF OPERATING OFFICER 10 Jun 2024, 18:46
ELVN Enliven Therapeutics, Inc. 14 May 2024 3 -$24,930 4 CHIEF OPERATING OFFICER 16 May 2024, 19:29
ELVN Enliven Therapeutics, Inc. 09 May 2024 3 -$5,871 4 CHIEF OPERATING OFFICER 13 May 2024, 19:35
ELVN Enliven Therapeutics, Inc. 06 May 2024 3 -$98,679 4 CHIEF OPERATING OFFICER 08 May 2024, 20:40
ELVN Enliven Therapeutics, Inc. 11 Apr 2024 3 -$401,139 4 CHIEF OPERATING OFFICER 15 Apr 2024, 19:06
ELVN Enliven Therapeutics, Inc. 08 Apr 2024 2 -$90,687 4 CHIEF OPERATING OFFICER 10 Apr 2024, 20:35
ELVN Enliven Therapeutics, Inc. 06 Mar 2024 1 -$76,239 4 CHIEF OPERATING OFFICER 08 Mar 2024, 19:52
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 CHIEF OPERATING OFFICER 15 Feb 2024, 21:02
ELVN Enliven Therapeutics, Inc. 06 Feb 2024 1 -$73,658 4 CHIEF OPERATING OFFICER 08 Feb 2024, 20:47
ELVN Enliven Therapeutics, Inc. 22 Jan 2024 1 -$73,783 4 Chief Operating Officer 24 Jan 2024, 18:38
ELVN Enliven Therapeutics, Inc. 28 Dec 2023 3 -$203,348 4 Chief Operating Officer 02 Jan 2024, 20:00
ELVN Enliven Therapeutics, Inc. 22 Dec 2023 2 -$16,306 4 Chief Operating Officer 27 Dec 2023, 17:28
ELVN Enliven Therapeutics, Inc. 04 Apr 2023 1 $0 4 Chief Operating Officer 06 Apr 2023, 20:34
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 5 $0 4 Chief Operating Officer 27 Feb 2023, 20:35
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Chief Operating Officer 27 Feb 2023, 20:26